| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | Neogenin_C | 2.45e-05 | 2 | 93 | 2 | IPR010560 | |
| Domain | Neogenin_C | 2.45e-05 | 2 | 93 | 2 | PF06583 | |
| Domain | REKLES_domain | 7.33e-05 | 3 | 93 | 2 | IPR023334 | |
| Domain | REKLES | 7.33e-05 | 3 | 93 | 2 | PS51486 | |
| Domain | Myosin_S1_N | 2.43e-04 | 5 | 93 | 2 | IPR008989 | |
| Domain | FN3 | 3.25e-04 | 185 | 93 | 6 | SM00060 | |
| Pubmed | Myosin X regulates netrin receptors and functions in axonal path-finding. | 9.21e-08 | 4 | 100 | 3 | 17237772 | |
| Pubmed | TMEM16A drives renal cyst growth by augmenting Ca2+ signaling in M1 cells. | 8.18e-06 | 2 | 100 | 2 | 32185407 | |
| Pubmed | Cyst growth in ADPKD is prevented by pharmacological and genetic inhibition of TMEM16A in vivo. | 8.18e-06 | 2 | 100 | 2 | 32859916 | |
| Pubmed | COL6A and LAMA2 Mutation Congenital Muscular Dystrophy: A Clinical and Electrophysiological Study. | 8.18e-06 | 2 | 100 | 2 | 29465610 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 18622425 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 35069585 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 27716118 | ||
| Pubmed | Antitumor immunity and prognosis value elicited by FAT3 and LRP1B co-mutation in endometrial cancer. | 8.18e-06 | 2 | 100 | 2 | 38696842 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 10838570 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 34199520 | ||
| Pubmed | Differential regulation of myosin X movements by its cargos, DCC and neogenin. | 2.45e-05 | 3 | 100 | 2 | 22349703 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 10843775 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 7707528 | ||
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 9441666 | ||
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 21955986 | ||
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 15494733 | ||
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 22084112 | ||
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 16244667 | ||
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 16723533 | ||
| Pubmed | Multiple congenital malformations of Wolf-Hirschhorn syndrome are recapitulated in Fgfrl1 null mice. | 4.89e-05 | 4 | 100 | 2 | 19383940 | |
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 18263604 | ||
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 37332102 | ||
| Pubmed | 8.14e-05 | 5 | 100 | 2 | 10704383 | ||
| Pubmed | 8.14e-05 | 5 | 100 | 2 | 17615572 | ||
| Pubmed | 8.14e-05 | 5 | 100 | 2 | 19774080 | ||
| Pubmed | Developmentally regulated expression of Netrin-1 and -3 in the embryonic mouse molar tooth germ. | 8.14e-05 | 5 | 100 | 2 | 12889066 | |
| Pubmed | 1.22e-04 | 6 | 100 | 2 | 10908620 | ||
| Pubmed | 1.22e-04 | 6 | 100 | 2 | 37831760 | ||
| Pubmed | 1.22e-04 | 6 | 100 | 2 | 24876346 | ||
| Pubmed | Genetic analysis of DSCAM's role as a Netrin-1 receptor in vertebrates. | 1.22e-04 | 6 | 100 | 2 | 22238077 | |
| Pubmed | Simultaneous binding of Guidance Cues NET1 and RGM blocks extracellular NEO1 signaling. | 1.22e-04 | 6 | 100 | 2 | 33740419 | |
| Pubmed | A genome-wide association meta-analysis identifies new childhood obesity loci. | 1.22e-04 | 6 | 100 | 2 | 22484627 | |
| Pubmed | 1.48e-04 | 92 | 100 | 4 | 37343697 | ||
| Pubmed | 1.70e-04 | 7 | 100 | 2 | 26397040 | ||
| Pubmed | Rb/E2F regulates expression of neogenin during neuronal migration. | 1.70e-04 | 7 | 100 | 2 | 21059867 | |
| Pubmed | Cloning of three mouse Unc5 genes and their expression patterns at mid-gestation. | 1.70e-04 | 7 | 100 | 2 | 12351186 | |
| Pubmed | 1.70e-04 | 7 | 100 | 2 | 12798294 | ||
| Pubmed | COL6A3 PDE4B FAT3 LAMA2 DALRD3 ZCCHC14 TNRC18 R3HCC1L PKD1 MLH1 ZFP69B DNPEP | 1.94e-04 | 1215 | 100 | 12 | 15146197 | |
| Pubmed | 1.96e-04 | 99 | 100 | 4 | 19730683 | ||
| Pubmed | 2.12e-04 | 187 | 100 | 5 | 26460568 | ||
| Pubmed | Floor plate and netrin-1 are involved in the migration and survival of inferior olivary neurons. | 2.27e-04 | 8 | 100 | 2 | 10341242 | |
| Pubmed | IL-22 induces Reg3γ and inhibits allergic inflammation in house dust mite-induced asthma models. | 2.27e-04 | 8 | 100 | 2 | 28811323 | |
| Pubmed | 2.51e-04 | 430 | 100 | 7 | 16303743 | ||
| Pubmed | 2.91e-04 | 9 | 100 | 2 | 35170427 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MYH10 MYO5A NSD2 FGFRL1 RNF213 ADGRL1 ATP9B ZSWIM6 ADGRV1 TNRC18 PTPRB PANK4 PATJ | 3.43e-04 | 1489 | 100 | 13 | 28611215 |
| Pubmed | 3.63e-04 | 10 | 100 | 2 | 15922553 | ||
| Pubmed | Characterization of a cluster comprising approximately 100 odorant receptor genes in mouse. | 3.63e-04 | 10 | 100 | 2 | 11130974 | |
| Pubmed | 3.94e-04 | 214 | 100 | 5 | 22199357 | ||
| Pubmed | Novel role for Netrins in regulating epithelial behavior during lung branching morphogenesis. | 4.43e-04 | 11 | 100 | 2 | 15186747 | |
| Pubmed | Analysis of Netrin 1 receptors during inner ear development. | 4.43e-04 | 11 | 100 | 2 | 17616930 | |
| Pubmed | 4.43e-04 | 11 | 100 | 2 | 29444422 | ||
| Pubmed | 5.14e-04 | 54 | 100 | 3 | 26273529 | ||
| Pubmed | Genome-wide association study of height and body mass index in Australian twin families. | 5.30e-04 | 12 | 100 | 2 | 20397748 | |
| Pubmed | 5.30e-04 | 12 | 100 | 2 | 11700294 | ||
| Pubmed | 6.25e-04 | 13 | 100 | 2 | 26257176 | ||
| Pubmed | 6.25e-04 | 13 | 100 | 2 | 18316482 | ||
| Pubmed | 8.39e-04 | 15 | 100 | 2 | 26395479 | ||
| Pubmed | CRL4-DCAF8L2 E3 ligase promotes ubiquitination and degradation of BARD1. | 8.39e-04 | 15 | 100 | 2 | 35487060 | |
| Pubmed | 8.46e-04 | 64 | 100 | 3 | 20332099 | ||
| Pubmed | 9.01e-04 | 257 | 100 | 5 | 16335952 | ||
| Pubmed | 9.57e-04 | 16 | 100 | 2 | 27223328 | ||
| Pubmed | Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women. | 9.57e-04 | 16 | 100 | 2 | 19415745 | |
| Pubmed | 9.93e-04 | 152 | 100 | 4 | 34299191 | ||
| Pubmed | 1.02e-03 | 153 | 100 | 4 | 25037231 | ||
| Pubmed | KMT2D regulates specific programs in heart development via histone H3 lysine 4 di-methylation. | 1.08e-03 | 17 | 100 | 2 | 26932671 | |
| Pubmed | Congenital Muscular Dystrophy Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY | 1.08e-03 | 17 | 100 | 2 | 20301468 | |
| Pubmed | Analysis of Expression Pattern and Genetic Deletion of Netrin5 in the Developing Mouse. | 1.08e-03 | 17 | 100 | 2 | 26858598 | |
| Pubmed | Assembly, verification, and initial annotation of the NIA mouse 7.4K cDNA clone set. | 1.12e-03 | 157 | 100 | 4 | 12466305 | |
| Pubmed | 1.27e-03 | 733 | 100 | 8 | 34672954 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ARID3A NSD2 CHSY1 FGFRL1 ADGRL1 EXTL3 ZCCHC14 TNRC18 SSH1 PKD1 | 1.32e-03 | 1105 | 100 | 10 | 35748872 |
| Pubmed | 1.50e-03 | 20 | 100 | 2 | 18669648 | ||
| Pubmed | 1.66e-03 | 21 | 100 | 2 | 37422473 | ||
| Pubmed | 1.66e-03 | 21 | 100 | 2 | 24923560 | ||
| Pubmed | 1.66e-03 | 21 | 100 | 2 | 25017104 | ||
| Pubmed | 1.66e-03 | 21 | 100 | 2 | 27270040 | ||
| Pubmed | Loss of Zeb2 in mesenchyme-derived nephrons causes primary glomerulocystic disease. | 1.66e-03 | 21 | 100 | 2 | 27591083 | |
| Pubmed | Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. | 1.82e-03 | 22 | 100 | 2 | 21512031 | |
| Pubmed | 1.82e-03 | 22 | 100 | 2 | 22726835 | ||
| Pubmed | 1.82e-03 | 22 | 100 | 2 | 37298108 | ||
| Pubmed | Crumbs2 promotes cell ingression during the epithelial-to-mesenchymal transition at gastrulation. | 1.82e-03 | 22 | 100 | 2 | 27870829 | |
| Pubmed | 1.99e-03 | 23 | 100 | 2 | 26659141 | ||
| Pubmed | 1.99e-03 | 23 | 100 | 2 | 36973253 | ||
| Pubmed | Synergistic integration of Netrin and ephrin axon guidance signals by spinal motor neurons. | 2.17e-03 | 24 | 100 | 2 | 26633881 | |
| Pubmed | 2.19e-03 | 89 | 100 | 3 | 24529757 | ||
| Pubmed | 2.26e-03 | 90 | 100 | 3 | 30228991 | ||
| Pubmed | 2.33e-03 | 91 | 100 | 3 | 21194568 | ||
| Pubmed | Common variants in left/right asymmetry genes and pathways are associated with relative hand skill. | 2.35e-03 | 25 | 100 | 2 | 24068947 | |
| Pubmed | Tubby family proteins are adapters for ciliary trafficking of integral membrane proteins. | 2.35e-03 | 25 | 100 | 2 | 28154160 | |
| Pubmed | 2.44e-03 | 814 | 100 | 8 | 23251661 | ||
| Pubmed | 2.54e-03 | 26 | 100 | 2 | 33238123 | ||
| Pubmed | Germline Saturation Mutagenesis Induces Skeletal Phenotypes in Mice. | 2.54e-03 | 26 | 100 | 2 | 33905568 | |
| Pubmed | The protomap is propagated to cortical plate neurons through an Eomes-dependent intermediate map. | 2.56e-03 | 94 | 100 | 3 | 23431145 | |
| Pubmed | Modulation of the combinatorial code of odorant receptor response patterns in odorant mixtures. | 2.74e-03 | 27 | 100 | 2 | 32061665 | |
| Pubmed | 2.74e-03 | 27 | 100 | 2 | 21510876 | ||
| Cytoband | 1p31.3 | 1.94e-04 | 51 | 100 | 3 | 1p31.3 | |
| Cytoband | 6q22-q23 | 2.09e-04 | 10 | 100 | 2 | 6q22-q23 | |
| Cytoband | 2q21.3 | 4.84e-04 | 15 | 100 | 2 | 2q21.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p31 | 1.50e-03 | 224 | 100 | 4 | chr1p31 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | NDNF COL6A3 COL9A1 PDE4B CFAP300 LCORL NSD2 BACE1 FGFRL1 CUBN DCC DALRD3 NEO1 CD82 AHR CEP295 EFCAB7 | 4.80e-07 | 1102 | 96 | 17 | M2369 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | NDNF COL6A3 COL9A1 PDE4B CFAP300 NSD2 BACE1 FGFRL1 CUBN DCC DALRD3 NEO1 CD82 AHR CEP295 EFCAB7 | 3.08e-06 | 1124 | 96 | 16 | MM1070 |
| Coexpression | RODRIGUES_DCC_TARGETS_DN | 5.12e-06 | 119 | 96 | 6 | M15927 | |
| Coexpression | GSE6259_CD4_TCELL_VS_CD8_TCELL_UP | 5.87e-06 | 187 | 96 | 7 | M6738 | |
| Coexpression | GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_6H_UP | 9.10e-06 | 200 | 96 | 7 | M9942 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | NDNF COL9A1 DDR2 ANO1 ST6GALNAC2 ZCCHC14 DUOX1 KIRREL1 TSLP ATP2B4 | 1.35e-05 | 493 | 96 | 10 | M19391 |
| ToppCell | LPS-IL1RA-Unknown-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.79e-07 | 118 | 100 | 6 | aefad0b35aff980b6a2a98057735442e8a65ab04 | |
| ToppCell | LPS-IL1RA-Unknown|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.79e-07 | 118 | 100 | 6 | 6cb4063b83f867b782080ce5b1199b51bb277f2a | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.15e-07 | 197 | 100 | 7 | 2ca5ebb708935a90b12b8e98a22ae2d664ed002e | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.48e-07 | 200 | 100 | 7 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 3.48e-07 | 200 | 100 | 7 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | LPS-IL1RA-Unknown-Endothelial-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.92e-07 | 125 | 100 | 6 | 2938a1d62afe1e0a3abba5eb92f07b886cc0accd | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.61e-06 | 159 | 100 | 6 | cb2470b288c13e454a2a80115b0d5613b3f718e6 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-06 | 160 | 100 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-06 | 160 | 100 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.37e-06 | 170 | 100 | 6 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-B_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-06 | 173 | 100 | 6 | 0a0cd40bb5f61431fe34758626c8a63ec610a8a5 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.80e-06 | 175 | 100 | 6 | 442f261a3b2c4d2523f7d4089178f8c79cac2f0f | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.80e-06 | 175 | 100 | 6 | 35fb7735dd3355476fe60404833cb60bd066bcf1 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.85e-06 | 185 | 100 | 6 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 4.10e-06 | 187 | 100 | 6 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.49e-06 | 190 | 100 | 6 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.49e-06 | 190 | 100 | 6 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.92e-06 | 193 | 100 | 6 | 4c74a3f69b2cbdf139e7e66b44bd86869ac34dc0 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.92e-06 | 193 | 100 | 6 | ff8ceeb3cfd1bef7239df490c19d181091750833 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.92e-06 | 193 | 100 | 6 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Mesenchymal|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 5.06e-06 | 194 | 100 | 6 | 638b9fdce64ed00243b5303800ec66207d5fd640 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Mesenchymal-choroid_plexus/mesenchymal-like_cells|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 5.06e-06 | 194 | 100 | 6 | e9868c22934b6c0ac35e3e8270ec0b671bc6582a | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.06e-06 | 194 | 100 | 6 | 8b81f039f5b25d35a4d5a41b27d4d9360ba22f15 | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 5.37e-06 | 196 | 100 | 6 | 2ce8a787f2731faa913d20342d73041d59468f27 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.69e-06 | 198 | 100 | 6 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.69e-06 | 198 | 100 | 6 | 7225a6194c52b01c581e58d3cda107c4af96dc4f | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.86e-06 | 199 | 100 | 6 | d65ee89d5c7e8ed693d58e6a6de09565840e11c5 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.86e-06 | 199 | 100 | 6 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.86e-06 | 199 | 100 | 6 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.86e-06 | 199 | 100 | 6 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.86e-06 | 199 | 100 | 6 | bf138cc692df727e087d140c014149ee5da00d9d | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.03e-06 | 200 | 100 | 6 | 16a7c398626b6e82b394eb3ef013bda3a788659d | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.03e-06 | 200 | 100 | 6 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.03e-06 | 200 | 100 | 6 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.03e-06 | 200 | 100 | 6 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.73e-05 | 142 | 100 | 5 | e160f35b3c18e77c4107fe96db5f56227c91785e | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.97e-05 | 146 | 100 | 5 | a317f14a1aab11ffcce65baeb1c475c04324315f | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 160 | 100 | 5 | 8a7a73b0ee1877fe02d47f745d36ae2858b529e1 | |
| ToppCell | VE-CD8-CD4_Treg|VE / Condition, Cell_class and T cell subcluster | 3.16e-05 | 161 | 100 | 5 | a114f4f75859d9ef900e5146686438d051241429 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 3.45e-05 | 164 | 100 | 5 | 9b4a6007abae992db871d9f6f731d5af724de30d | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Plasma_cells-IgG_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.87e-05 | 168 | 100 | 5 | f5a18123f84c62211d9279e9c41e90122e4c4895 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-05 | 169 | 100 | 5 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.09e-05 | 170 | 100 | 5 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.21e-05 | 171 | 100 | 5 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.21e-05 | 171 | 100 | 5 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.57e-05 | 174 | 100 | 5 | a1f745962a104c6f4b86b7e482da8755384c773a | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.70e-05 | 175 | 100 | 5 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.70e-05 | 175 | 100 | 5 | 282f09bbdfa70d93b3f66591dcfb84c5ee0268c7 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.70e-05 | 175 | 100 | 5 | 6a093c74a6f3daeff07759d6eec542fc5c709149 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-05 | 175 | 100 | 5 | 0992de1c7bffcb6890584357a7a0a8955927da6c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 5.51e-05 | 181 | 100 | 5 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 5.66e-05 | 182 | 100 | 5 | ceb37c214662a48efb56ab0d015977c6fab478b0 | |
| ToppCell | E18.5-samps|World / Age Group, Lineage, Cell class and subclass | 5.66e-05 | 182 | 100 | 5 | 9649f15858d1ede73e068afc59df3ac367b49687 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.80e-05 | 183 | 100 | 5 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.80e-05 | 183 | 100 | 5 | ebe369dc80c4fbf8f4dbe947147f8c47507ffb60 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-05 | 184 | 100 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-05 | 184 | 100 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-05 | 184 | 100 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.11e-05 | 185 | 100 | 5 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-05 | 185 | 100 | 5 | 38486b69c48dc5e1c4e1488208fa8954a973eccb | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.11e-05 | 185 | 100 | 5 | a6874dd3030d04380cc3c01de1069461aad4ef45 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-05 | 185 | 100 | 5 | 3c28b5ceba3cfdb6f7e32d5b42e03b6a81a7a658 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.27e-05 | 186 | 100 | 5 | 055cc23c4db9aad2d6c62e62c8e58bfe5047c6b1 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 6.59e-05 | 188 | 100 | 5 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.59e-05 | 188 | 100 | 5 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.76e-05 | 189 | 100 | 5 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 6.76e-05 | 189 | 100 | 5 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.93e-05 | 190 | 100 | 5 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.93e-05 | 190 | 100 | 5 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.93e-05 | 190 | 100 | 5 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 6.93e-05 | 190 | 100 | 5 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.11e-05 | 191 | 100 | 5 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.11e-05 | 191 | 100 | 5 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.11e-05 | 191 | 100 | 5 | 8a73d2df079566fca4cbb5cdb85721c2e87134c8 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.11e-05 | 191 | 100 | 5 | beb5bb42bd53bce01339da9110d374901548793c | |
| ToppCell | E15.5-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.11e-05 | 191 | 100 | 5 | 402c341b00f98e8215458766b3c219fff8dcb447 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.11e-05 | 191 | 100 | 5 | 6609d85fd2577633dcc067507304a6f9e5865ca3 | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.11e-05 | 191 | 100 | 5 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.11e-05 | 191 | 100 | 5 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.11e-05 | 191 | 100 | 5 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 7.11e-05 | 191 | 100 | 5 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | 15-Trachea-Epithelial-Submucosal_gland_basal|Trachea / Age, Tissue, Lineage and Cell class | 7.11e-05 | 191 | 100 | 5 | 409e12d2bb26b6d2ed025304ca6ace07df16638a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.11e-05 | 191 | 100 | 5 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.11e-05 | 191 | 100 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | droplet-Lung-21m-Mesenchymal|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.11e-05 | 191 | 100 | 5 | 10a9db1caa0fdb51ace8537f42b2c66f7c97e0f5 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.28e-05 | 192 | 100 | 5 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.28e-05 | 192 | 100 | 5 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.28e-05 | 192 | 100 | 5 | ff4b728a55c2550c806c47e9ae3d057c35df8464 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-alveolar_fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.28e-05 | 192 | 100 | 5 | 2d3790bd80a7f214b37094121a2a86ff16362569 | |
| ToppCell | E15.5-Epithelial-alveolar_epithelial_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.28e-05 | 192 | 100 | 5 | 567f4355a01aae1f2eafc16fe86d1538a62030ab | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 7.28e-05 | 192 | 100 | 5 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.46e-05 | 193 | 100 | 5 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 7.46e-05 | 193 | 100 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.46e-05 | 193 | 100 | 5 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 7.46e-05 | 193 | 100 | 5 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.46e-05 | 193 | 100 | 5 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.46e-05 | 193 | 100 | 5 | e2b455387d1de7812305200a2041a0f4759a6f54 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.65e-05 | 194 | 100 | 5 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 7.65e-05 | 194 | 100 | 5 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-05 | 194 | 100 | 5 | ee6b5fb4e993a4c0dc556091b8fefd56bdc70d8f | |
| Computational | Adhesion molecules. | 1.41e-04 | 141 | 61 | 6 | MODULE_122 | |
| Disease | Alzheimer disease, APOE carrier status | 1.35e-05 | 98 | 91 | 5 | EFO_0007659, MONDO_0004975 | |
| Disease | Wolf-Hirschhorn syndrome (implicated_via_orthology) | 5.62e-05 | 4 | 91 | 2 | DOID:0050460 (implicated_via_orthology) | |
| Disease | serum alanine aminotransferase measurement, response to combination chemotherapy | 7.02e-05 | 71 | 91 | 4 | EFO_0004735, EFO_0007965 | |
| Disease | AP-4 complex subunit mu-1 measurement | 9.35e-05 | 5 | 91 | 2 | EFO_0801385 | |
| Disease | body weight | NDNF LRRC66 PDE4B LCORL ANO1 ZSWIM6 ADGRV1 DCC LRP1B PKD1 RRH PATJ ATP2B4 | 1.29e-04 | 1261 | 91 | 13 | EFO_0004338 |
| Disease | 4p partial monosomy syndrome | 1.40e-04 | 6 | 91 | 2 | cv:C1956097 | |
| Disease | WOLF-HIRSCHHORN SYNDROME | 1.40e-04 | 6 | 91 | 2 | 194190 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 1.82e-04 | 169 | 91 | 5 | DOID:3908 (is_marker_for) | |
| Disease | Pitt-Rogers-Danks Syndrome | 2.60e-04 | 8 | 91 | 2 | C0796117 | |
| Disease | Wolf-Hirschhorn Syndrome | 3.34e-04 | 9 | 91 | 2 | C1956097 | |
| Disease | Early Pregnancy Loss | 3.68e-04 | 109 | 91 | 4 | C3830362 | |
| Disease | Spontaneous abortion | 3.68e-04 | 109 | 91 | 4 | C0000786 | |
| Disease | Miscarriage | 3.68e-04 | 109 | 91 | 4 | C4552766 | |
| Disease | Abortion, Tubal | 3.68e-04 | 109 | 91 | 4 | C0000822 | |
| Disease | colorectal cancer (is_implicated_in) | 5.46e-04 | 121 | 91 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | rheumatoid arthritis | 5.76e-04 | 462 | 91 | 7 | EFO_0000685 | |
| Disease | Birth Weight | 8.36e-04 | 14 | 91 | 2 | C0005612 | |
| Disease | cortical surface area measurement | MYH10 LCORL FAT3 LAMA2 FGFRL1 EXTL3 ADGRV1 NEO1 SLAMF6 PKD1 MLH1 MAP4K4 | 8.67e-04 | 1345 | 91 | 12 | EFO_0010736 |
| Disease | Myopia | 9.62e-04 | 15 | 91 | 2 | C0027092 | |
| Disease | aortic measurement | 1.10e-03 | 251 | 91 | 5 | EFO_0020865 | |
| Disease | response to radiation, Urinary retention | 1.24e-03 | 17 | 91 | 2 | GO_0009314, HP_0000016 | |
| Disease | muscular dystrophy (is_implicated_in) | 1.24e-03 | 17 | 91 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | asthma, age at onset | 1.34e-03 | 70 | 91 | 3 | EFO_0004847, MONDO_0004979 | |
| Disease | neuroimaging measurement | 1.69e-03 | 1069 | 91 | 10 | EFO_0004346 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 2.43e-03 | 301 | 91 | 5 | DOID:684 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MTVTYSSKVANATFF | 1 | Q8N1M1 | |
| MNSSSANITYASRKR | 1 | P35869 | |
| NFMKTRGTSFLNAYT | 61 | Q6UWY0 | |
| YKFAISQSSTGTVMG | 381 | P56817 | |
| SKSTAAMSTYTGIFT | 76 | P02655 | |
| ESKYFMTRNSSTIIA | 71 | Q9ULA0 | |
| TITSAAFTLRTQYMK | 181 | A6NKF2 | |
| KTSAMRSNTRYYTGT | 1131 | O94910 | |
| TTSSRMAKKNYVGIS | 361 | Q15760 | |
| LATYSGQTAMKLASS | 1591 | Q5H9F3 | |
| TYRKNMTRVASLFSG | 2481 | Q8WXG9 | |
| SATRKVNTGFLMSSY | 86 | Q7Z6K5 | |
| SAVCKTTTYFMGTSV | 111 | P32238 | |
| RYTYNGATSVMSSRT | 191 | P78369 | |
| YTFNSVRKSMSTVIR | 566 | P23634 | |
| MGKLYNFSTSSRSQD | 386 | Q96QP1 | |
| QTSSSSLRMGAYVFI | 46 | P27701 | |
| SINTRSFSKFVGMSA | 406 | Q7Z5L2 | |
| SVGKTSIISRFMYNS | 41 | Q5JT25 | |
| KNDRSFVSYTMTVIA | 181 | O14718 | |
| SRGTAASISFMFSYI | 1086 | Q9NRD9 | |
| SSMDQGKVSSVFYTI | 266 | Q15617 | |
| SSMDQGKVSSVFYTI | 301 | Q8NG78 | |
| YEFSVMVTKNRRSST | 916 | P43146 | |
| ASVRSGGSSQVYFMT | 1216 | O95819 | |
| YMATVTSISGDLKNS | 531 | P23467 | |
| RFVFSMDTSASTAYL | 86 | A0A0B4J1V7 | |
| VFYLNGSKMATLSSV | 216 | Q9NZR2 | |
| ISNFSMTVDGKTFRS | 116 | P19823 | |
| RKTSYIVQVMASTSA | 486 | Q8NI17 | |
| SSDVRTVSYTNLKFM | 676 | Q16832 | |
| STSYAQKFQGRVTMT | 76 | P01743 | |
| SSRKTYTFDMVFGAS | 61 | P52732 | |
| IYTGKETRSVMNTSN | 351 | O43861 | |
| MYQVSKTSSVLEGSA | 436 | Q8N3X6 | |
| FSMARETVGYSSSSA | 266 | Q9NXR8 | |
| ANTMGYSFRSAFLTV | 341 | Q8N441 | |
| IQTYRSVSEMASNKF | 236 | Q07343 | |
| SKMAAGTSTFVVAYA | 141 | Q96KR6 | |
| MSRYSSSGYSSAEQI | 121 | Q8IW50 | |
| TARTSSYKAMEAASS | 566 | O96028 | |
| SNMSTAYVGTFARTK | 321 | Q8TB73 | |
| ISTVMFKFRTFSSSA | 2361 | P24043 | |
| RTTCTKAKYSMGITS | 256 | Q5XXA6 | |
| ALASYVSMSAQSGVV | 496 | Q9Y5G0 | |
| YFTGIMTNASRKSNI | 16 | Q68CR7 | |
| RSMAYGLVSATFAAS | 156 | Q96MC6 | |
| RGQAYIVSSGFSSKM | 326 | O43422 | |
| VTMRTITYSINFFSK | 331 | Q9NVE7 | |
| SSRSGSAADQAKMYS | 261 | P0C628 | |
| TSSVFKVSAYDSAGM | 216 | Q9BRQ4 | |
| KSGVVNRNSRMSFTY | 3376 | O60494 | |
| FKTSVSFTVTMGANG | 241 | A8K855 | |
| VSTGRAMVAQSTFYT | 291 | O43909 | |
| FKSAAMTLNERFTSY | 621 | Q9NYF8 | |
| FKSRYTGINQFMTET | 2416 | O75417 | |
| RTMFSLDTYSTKAQV | 291 | P12111 | |
| GMVSSRKQFTAGSYD | 1311 | Q8TDW7 | |
| VYQKTTFSSRMKSHS | 56 | Q502W7 | |
| YTGANQSRMAVSKTV | 81 | Q5VTH9 | |
| VSTATRVMKAIYSSF | 561 | Q96J84 | |
| SISTKGTKSGTFVMY | 391 | Q5D0E6 | |
| YSFLTTFRMTGSTLK | 111 | P20849 | |
| SKSTVYFTALRRTSM | 2121 | Q9C0D2 | |
| SYGSSKAAVTMFSSV | 231 | P37059 | |
| FVSGEAVSAYSSAMR | 551 | Q8IZU8 | |
| ATDFAYSSTVRQNMK | 476 | P07358 | |
| SPSTSFTSGSMYRIK | 16 | Q92613 | |
| SITYQMFGKTLSGTN | 936 | Q56UN5 | |
| VTGMTETAFGSAYKT | 631 | P35580 | |
| NYTVSTKVASMAFQT | 2841 | P98161 | |
| DMEIKNYSSSTSGFI | 36 | Q8NGR2 | |
| TTAAKALMSAFYTFR | 226 | P24347 | |
| SSMDQRKVSSVFYTT | 266 | P0DMU2 | |
| MEDTGSYRAQISTKT | 101 | Q96DU3 | |
| SSFTSAKEFLMNRGS | 921 | B5MCY1 | |
| ASTKAYTSQFVSLVM | 491 | Q06210 | |
| TYNTTSAVMVKSAIR | 71 | A6NKH3 | |
| DNSRYKMSSSFLGSQ | 826 | Q96RN1 | |
| YEFSVMVTKGRRSST | 926 | Q92859 | |
| FYGFTVNTMKNSLVS | 196 | Q9UJ37 | |
| FSYSRIASSIRKMSS | 216 | Q96RA2 | |
| ESKLLGSNSSRMYFT | 331 | P40692 | |
| YSTEASTGNMVISKL | 396 | Q6UX06 | |
| GVSRSASTVIAYAMK | 396 | Q8WYL5 | |
| SITSAAFTLRTQYMK | 306 | Q99856 | |
| SKASTYGSTQQLAEM | 766 | Q86X52 | |
| EVFTKNMLTSSGASF | 916 | Q63HN8 | |
| NMLTSSGASFTYVKE | 921 | Q63HN8 | |
| EASAMQSLIKYSGSF | 581 | O15417 | |
| MTFSENTKSNGRYTA | 71 | A0A0B4J240 | |
| FGNSKYQNRRTMSSS | 96 | Q00403 | |
| SKASAYTGMLSSRYA | 1026 | Q8NI35 | |
| LITYMSGTKSTEFNN | 51 | Q969D9 | |
| SGKTSMRSIIFANYI | 51 | Q5VZM2 | |
| LYTANTKVAFSAMSS | 676 | Q8WYQ9 | |
| KNAISATAERFSGYM | 411 | Q86T82 | |
| ATTGMSYTQLFTIAR | 1021 | Q9HCJ5 | |
| FTKGSSMYSTLGRIS | 176 | Q9UJL9 | |
| YAAKNAVTQFVSSMS | 136 | P0C7P4 | |
| AFTVSVMRYSASAFG | 106 | Q8TC26 | |
| AMRYFATVSGSASEA | 176 | Q9Y4I1 |